Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial.
Jeyanathan M, Afkhami S, D'Agostino MR, Satia I, Fritz DK, Miyasaki K, Ang JC, Zganiacz A, Howie KJ, Swinton M, Aguirre E, Zheng MB, Kazhdan N, Dvorkin-Gheva A, Mbuagbaw L, Medina MFC, Diab N, Brister DL, Gauvreau GM, Lichty BD, Miller MS, Smaill F, Xing Z.
Jeyanathan M, et al. Among authors: medina mfc.
Nat Commun. 2025 Jul 2;16(1):6000. doi: 10.1038/s41467-025-60726-0.
Nat Commun. 2025.
PMID: 40603330
Free PMC article.
Clinical Trial.